Sign In
Buy IART
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
11:06am, Wednesday, 17'th Apr 2024
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Investors Should Retain Integra (IART) Stock Now
09:46am, Tuesday, 09'th Apr 2024
Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
04:15pm, Monday, 01'st Apr 2024
PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed
Why Is Integra (IART) Down 4% Since Last Earnings Report?
12:36pm, Friday, 29'th Mar 2024
Integra (IART) reported earnings 30 days ago. What's next for the stock?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
05:20pm, Monday, 25'th Mar 2024
NEW YORK , March 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating whether the Board of Directors of Integra Lifesciences Holdings Corp (NASDAQ: IART) ("Integra") potentially breached their fidu
Integra LifeSciences (IART) Introduces MicroMatrix Flex
01:06pm, Tuesday, 12'th Mar 2024
Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
08:30am, Monday, 11'th Mar 2024
Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matrix (UBM) technology Novel system features flexible tip to deliver flowable version of the Urinary Bladder Matr
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Integra's (IART) Q4 Earnings Miss Estimates, Margins Down
11:46am, Thursday, 29'th Feb 2024
Integra's (IART) Q4 revenues are impacted by the decline in the Tissue Technologies segment.
Integra LifeSciences Holdings Corporation (IART) Q4 2023 Earnings Call Transcript
01:51pm, Wednesday, 28'th Feb 2024
Integra LifeSciences Holdings Corporation (IART) Q4 2023 Earnings Call Transcript
Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics
10:36am, Wednesday, 28'th Feb 2024
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates
08:16am, Wednesday, 28'th Feb 2024
Integra LifeSciences (IART) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.94 per share a year ago.
Integra (IART) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:21am, Monday, 26'th Feb 2024
Besides Wall Street's top -and-bottom-line estimates for Integra (IART), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline
11:06am, Wednesday, 21'st Feb 2024
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
09:15am, Wednesday, 07'th Feb 2024
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 202
